News About: Pharm. Industry
Biopharmaceutical firms grapping with recruitment of talented people
In sharp contrast with today's drying-up job market in young people, biopharmaceutical firms have faced serious shortage of talented human resources with proper professional knowledge.
Business sources say that tal...
Large packaged drugs to investigate its quality.
The Korea Pharmaceutical Association (KPA) is going to request an overall investigation over the large packaged drugs that were suspected of its quality.
The Illicit and Substandard Drug Report Center affiliated ...
Whanin Pharm seeking suit to confirm non-presence of liabilities over Merck-Lipha
Whanin Pharm said it is seeking a local court's ruling over the liabilities incurred out of an annulled secrecy agreement executed earlier with France-based Merck-Lipha, while
According to Whanin, the company had ...
Calcium antagonists led domestic antihypertensive market in first half
Calcium antagonists, such as Norvasc, Adalat Oros and Zanidip, led the local antihypertensive drugs market in the first half of this year, according to KPMR report of 120 wholesalers released by Bestcare, drug whole...
New applicants for drug company employment prefer sales jobs.
A great number of new applicants for the company employment prefer the sales job which had been regarded as one of 3D jobs (difficult, danger and dirty job) probably as a result of the recent protracted business slow ...
Pharmaceutical industry on recovery track
Amid deepened business slump, overall pharmaceutical business condition has improved after the third quarter of this year and leading domestic pharmaceutical firms are grappling with their lackluster sales via aggress...
Anti-hangover drink market getting heated
With the year-end coming at hand, some pharmaceutical firms are staging their aggressive marketing campaigns to boost the sales in domestic anti-hangover drink market.
The anti-hangover drink market has continuousl...
Finished pharmaceutical imports grow 45 percent in third quarter
Recent statistics showed that finished pharmaceutical imports through the third quarter of this year surged 45 percent to $220 million from a year ago.
According to the tallies released by the Korea Pharmaceutical ...
Hanwha Pharm ordeded to distribute Livial
The Seoul District Court accepted on November 25 the request of Hanwha Pharm to seek an injunction trial against the Korea Food and Drug Administration to invalidate cancellation of the product license of Livial, a fi...
Green Cross PBM and PDPS merged.
Green Cross PBM, a drug and quasi-drug manufacture and distribution company with 6.4 billion won of equity, determined in their directorate meeting on Nov. 24 that they took an M&A with Green Cross PD, R&D and PS alto...
